These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 15507580)

  • 1. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.
    Laheij RJ; Sturkenboom MC; Hassing RJ; Dieleman J; Stricker BH; Jansen JB
    JAMA; 2004 Oct; 292(16):1955-60. PubMed ID: 15507580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs.
    Eurich DT; Sadowski CA; Simpson SH; Marrie TJ; Majumdar SR
    Am J Med; 2010 Jan; 123(1):47-53. PubMed ID: 20102991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.
    Dial S; Delaney JA; Barkun AN; Suissa S
    JAMA; 2005 Dec; 294(23):2989-95. PubMed ID: 16414946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acid-suppressive medication use and the risk for hospital-acquired pneumonia.
    Herzig SJ; Howell MD; Ngo LH; Marcantonio ER
    JAMA; 2009 May; 301(20):2120-8. PubMed ID: 19470989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
    Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
    Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acid-suppressive drugs and community-acquired pneumonia.
    Rodríguez LA; Ruigómez A; Wallander MA; Johansson S
    Epidemiology; 2009 Nov; 20(6):800-6. PubMed ID: 19797970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study.
    Gulmez SE; Holm A; Frederiksen H; Jensen TG; Pedersen C; Hallas J
    Arch Intern Med; 2007 May; 167(9):950-5. PubMed ID: 17502537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Increased risk of pneumonia through gastric acid reduction. Partial evaluation of the Integrated Primary Care Information Project (IPCIP)].
    Nitschmann S
    Internist (Berl); 2006 Apr; 47(4):441-2; discussion 442. PubMed ID: 16511690
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term proton pump inhibitor therapy and risk of hip fracture.
    Yang YX; Lewis JD; Epstein S; Metz DC
    JAMA; 2006 Dec; 296(24):2947-53. PubMed ID: 17190895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.
    Dublin S; Walker RL; Jackson ML; Nelson JC; Weiss NS; Jackson LA
    Pharmacoepidemiol Drug Saf; 2010 Aug; 19(8):792-802. PubMed ID: 20623507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community-acquired pneumonia and use of gastric acid-suppressive drugs.
    Sataloff RT
    JAMA; 2005 Feb; 293(7):795-6; author reply 796. PubMed ID: 15713765
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study.
    Myles PR; Hubbard RB; McKeever TM; Pogson Z; Smith CJ; Gibson JE
    Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):269-75. PubMed ID: 19235776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton-pump inhibitor use and the risk for community-acquired pneumonia.
    Sarkar M; Hennessy S; Yang YX
    Ann Intern Med; 2008 Sep; 149(6):391-8. PubMed ID: 18794558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric acid-suppressive therapy and community-acquired respiratory infections.
    Laheij RJ; Van Ijzendoorn MC; Janssen MJ; Jansen JB
    Aliment Pharmacol Ther; 2003 Oct; 18(8):847-51. PubMed ID: 14535879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of post-stroke pneumonia with proton pump inhibitors, H2 receptor antagonists and mucoprotective agents: A retrospective nationwide cohort study.
    Song TJ; Kim J
    PLoS One; 2019; 14(5):e0216750. PubMed ID: 31067267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid suppression and pneumonia: a clinical indication for rational prescribing.
    Gregor JC
    JAMA; 2004 Oct; 292(16):2012-3. PubMed ID: 15507589
    [No Abstract]   [Full Text] [Related]  

  • 17. Association between use of acid-suppressive drugs and risk of gastric cancer. A nested case-control study.
    Tamim H; Duranceau A; Chen LQ; Lelorier J
    Drug Saf; 2008; 31(8):675-84. PubMed ID: 18636786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists and Risk of Pneumonia in Patients with Acute Stroke.
    Momosaki R; Yasunaga H; Matsui H; Fushimi K; Abo M
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1035-1040. PubMed ID: 26853142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipeptidyl peptidase-4 inhibitors and the risk of community-acquired pneumonia in patients with type 2 diabetes.
    Faillie JL; Filion KB; Patenaude V; Ernst P; Azoulay L
    Diabetes Obes Metab; 2015 Apr; 17(4):379-85. PubMed ID: 25581902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.